Charlene A. Banard Atara Biotherapeutics, Inc. (ATRA) insider trading activity

Charlene A. Banard is EVP, Chief Technical Officer of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 276,010 shares of ATRA, which is worth approximately $2.13 Million. The most recent transaction as insider was on May 16, 2023, when has been sold 19,040 shares (Common Stock) at a price of $2.04 per share, resulting in proceeds of $38,841. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 276K

0% 3M change

0% 12M change

Total Value Held $2.13 Million

Charlene A. Banard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 16 2023	SELL Open market or private sale	$38,841 $2.04 p/Share	19,040 Reduced 6.45%	276,010 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	139,700 Added 32.13%	295,050 Common Stock

Also insider at

AMTI

Applied Molecular Transport Inc. Healthcare

Director

CAB